Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Anti-Cancer Drugs|April 4, 2009
Rhein lysinate suppresses the growth of breast cancer cells and potentiates the inhibitory effect of Taxol in athymic miceYa-Jun Lin, Yong-Su ZhenActa Pharmacologica Sinica|July 4, 2009
Lidamycin shows highly potent cytotoxic to myeloma cells and inhibits tumor growth in miceYong-Zhan Zhen, Ya-Jun Lin, Yi Li, et al.The American Journal of Chinese Medicine|November 4, 2009
Rhein lysinate suppresses the growth of tumor cells and increases the anti-tumor activity of Taxol in miceYa-Jun Lin, Yong-Zhan Zhen, Bo-Yang Shang, et al.International Journal of Hematology|May 27, 2009
Enediyne lidamycin induces apoptosis in human multiple myeloma cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinaseYong-Zhan Zhen, Ya-Jun Lin, Bo-Yang Shang, et al.The American Journal of Chinese Medicine|July 2, 2011
Rhein lysinate induced S-phase arrest and increased the anti-tumor activity of 5-FU in HeLa cellsYa-Jun Lin, Yong-Zhan Zhen, Yu-Fang Zhao, et al.Acta Pharmacologica Sinica|September 13, 2011
Effects of Rhein lysinate on H2O2-induced cellular senescence of human umbilical vascular endothelial cellsYa-jun Lin, Yong-zhan Zhen, Jie Wei, et al.Yao Xue Xue Bao = Acta Pharmaceutica Sinica|February 26, 2009
[Rhein lysinate induces apoptosis in breast cancer SK-Br-3 cells by inhibiting HER-2 signal pathway]Ya-Jun Lin, Yun-Hong Huang, Yong-Zhan Zhen, et al.Anti-Cancer Drugs|May 24, 2013
Bortezomid enhances the efficacy of lidamycin against human multiple myeloma cellsYong-Zhan Zhen, Ya-Jun Lin, Xiu-Jun Liu, et al.Oncology Letters|August 8, 2012
Rhein lysinate inhibits cell growth by modulating various mitogen-activated protein kinases in cervical cancer cellsYong-Zhan Zhen, Ya-Jun Lin, Jun-Ling Gao, et al.Molecular Medicine Reports|May 3, 2014
KNDC1 knockdown protects human umbilical vein endothelial cells from senescenceChunyan Zhang, Yong-Zhan Zhen, Ya-Jun Lin, et al.Pageof 3